SCHEMBL4190033

SCHEMBL4190033

COC(=O)c1ccc(S(=O)(=O)Nc2ccccc2CN[C@@H](C)CC2CCCC2)n1C

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
NPSR1 Q6W5P4 2/20 0.44
LMNA P02545 2/20 0.42
ATM Q13315 2/20 0.41
MAPK1 P28482 1/20 0.41
NPC1 O15118 1/20 0.40
BCL2 P10415 1/20 0.37
BCL2L1 Q07817 1/20 0.37
KDM4E B2RXH2 2/20 0.37
PKM P14618 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33
KMT2A Q03164 1/20 0.33
TP53 P04637 1/20 0.32
ALOX15 P16050 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CYP2D6 P10635 1/20 0.32
OPRK1 P41145 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4188478 0.99 NPSR1 (0.46) ALDH1A1NPSR1LMNAATMMAPK1
SCHEMBL14343949 0.80 KDM4E (0.38) ALDH1A1LMNAATMKDM4EPKM
SCHEMBL4200028 0.80 CCKBR (0.44) ALDH1A1NPSR1LMNAKDM4EPKM
SCHEMBL4196685 0.79 CCKBR (0.44) ALDH1A1NPSR1LMNANPC1KDM4E
SCHEMBL4197715 0.79 CCKBR (0.44) ALDH1A1NPSR1LMNANPC1KDM4E
SCHEMBL4191171 0.79 CCKBR (0.45) ALDH1A1NPSR1LMNAKDM4EPKM
SCHEMBL4201643 0.79 MCL1 (0.44) ALDH1A1NPSR1KDM4EPKMMEN1
SCHEMBL4198259 0.79 PPARG (0.47) ALDH1A1NPSR1LMNASMN1; SMN2MEN1
SCHEMBL4190745 0.78 MCL1 (0.43) KDM4EPKMSMN1; SMN2KMT2A
SCHEMBL4196808 0.78 MCL1 (0.43) KDM4EPKMSMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 ALDH1A1 2744/4885NPSR1 4068/4885LMNA 2332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.